147 related articles for article (PubMed ID: 38491114)
1. Plasma extracellular vesicle microRNAs reflecting the therapeutic effect of the CBP/β-catenin inhibitor PRI-724 in patients with liver cirrhosis.
Yoshida M; Matsuzaki J; Fujita K; Kimura M; Umezu T; Tokuda N; Yamaguchi T; Kuroda M; Ochiya T; Saito Y; Kimura K
Sci Rep; 2024 Mar; 14(1):6266. PubMed ID: 38491114
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study.
Kimura K; Kanto T; Shimoda S; Harada K; Kimura M; Nishikawa K; Imamura J; Ogawa E; Saio M; Ikura Y; Okusaka T; Inoue K; Ishikawa T; Ieiri I; Kishimoto J; Todaka K; Kamisawa T
EBioMedicine; 2022 Jun; 80():104069. PubMed ID: 35605429
[TBL] [Abstract][Full Text] [Related]
3. Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial.
Kimura K; Ikoma A; Shibakawa M; Shimoda S; Harada K; Saio M; Imamura J; Osawa Y; Kimura M; Nishikawa K; Okusaka T; Morita S; Inoue K; Kanto T; Todaka K; Nakanishi Y; Kohara M; Mizokami M
EBioMedicine; 2017 Sep; 23():79-87. PubMed ID: 28844410
[TBL] [Abstract][Full Text] [Related]
4. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
[No Abstract] [Full Text] [Related]
5. Increased serum extracellular vesicle miR-144-3p and miR-486a-3p in a mouse model of adipose tissue regeneration promote hepatocyte proliferation by targeting Txnip.
Niitsu Y; Komiya C; Takeuchi A; Hara K; Horino M; Aoki J; Okazaki R; Murakami M; Tsujimoto K; Ikeda K; Yamada T
PLoS One; 2023; 18(5):e0284989. PubMed ID: 37141242
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model.
Tokunaga Y; Osawa Y; Ohtsuki T; Hayashi Y; Yamaji K; Yamane D; Hara M; Munekata K; Tsukiyama-Kohara K; Hishima T; Kojima S; Kimura K; Kohara M
Sci Rep; 2017 Mar; 7(1):325. PubMed ID: 28336942
[TBL] [Abstract][Full Text] [Related]
7. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
Yu F; Fan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
[TBL] [Abstract][Full Text] [Related]
8. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling.
Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J
Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231
[TBL] [Abstract][Full Text] [Related]
9. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
Barone I; Gelsomino L; Accattatis FM; Giordano F; Gyorffy B; Panza S; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Bonofiglio D; Andò S; Giordano C; Catalano S
J Transl Med; 2023 Mar; 21(1):232. PubMed ID: 37004031
[TBL] [Abstract][Full Text] [Related]
10. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing.
Liu X; Ma H; Wu R; Wang H; Xu H; Li S; Wang G; Lv G; Niu J
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553468
[TBL] [Abstract][Full Text] [Related]
11. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation.
Messner CJ; Schmidt S; Özkul D; Gaiser C; Terracciano L; Krähenbühl S; Suter-Dick L
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575957
[TBL] [Abstract][Full Text] [Related]
12. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232
[TBL] [Abstract][Full Text] [Related]
13. Astaxanthin Attenuates the Changes in the Expression of MicroRNAs Involved in the Activation of Hepatic Stellate Cells.
Bae M; Kim MB; Lee JY
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267937
[TBL] [Abstract][Full Text] [Related]
14. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma.
Gabata R; Harada K; Mizutani Y; Ouchi H; Yoshimura K; Sato Y; Kitao A; Kimura K; Kouji H; Miyashita T; Tajima H; Ohta T
Anticancer Res; 2020 Sep; 40(9):5211-5219. PubMed ID: 32878809
[TBL] [Abstract][Full Text] [Related]
16. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles from miR-148a-5p-Enriched Bone Marrow Mesenchymal Stem Cells Relieve Hepatic Fibrosis by Targeting Smad4.
Xuan J; Xu H; Li H; Chen D; Qiu Y; Chen X; Shao M; Xia X
Mol Biotechnol; 2022 May; 64(5):535-545. PubMed ID: 35006577
[TBL] [Abstract][Full Text] [Related]
18. Combining plasma extracellular vesicle Let-7b-5p, miR-184 and circulating miR-22-3p levels for NSCLC diagnosis and drug resistance prediction.
Vadla GP; Daghat B; Patterson N; Ahmad V; Perez G; Garcia A; Manjunath Y; Kaifi JT; Li G; Chabu CY
Sci Rep; 2022 Apr; 12(1):6693. PubMed ID: 35461372
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types.
Wang X; Seo W; Park SH; Fu Y; Hwang S; Rodrigues RM; Feng D; Gao B; He Y
Int J Biol Sci; 2021; 17(4):1153-1167. PubMed ID: 33867837
[No Abstract] [Full Text] [Related]
20. Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs.
Nishikawa K; Osawa Y; Kimura K
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
